Dysregulating IRES-dependent translation contributes to overexpression of oncogenic aurora a kinase

Molecular Cancer Research

Volumn 11, Issue 8, 2013, Pages 887-900

  Dobson, Tara ^a   Chen, Juan ^b   Krushel, Les A ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; RNA;

ARTICLE; BREAST CELL; BREAST EPITHELIUM; CANCER GROWTH; CARCINOGENICITY; CELL CYCLE; CELL IMMORTALIZATION; CONTROLLED STUDY; FIBROBLAST CULTURE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STABILITY; RNA TRANSLATION;

5' UNTRANSLATED REGIONS; AURORA KINASE A; CARCINOGENESIS; CELL LINE; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MCF-7 CELLS; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; RIBOSOMES; RNA CAPS; RNA, MESSENGER;

EID: 84882764847     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-12-0707     Document Type: Article

References (97)

1. Adams RR, Carmena M, Earnshaw WC. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 2001;11:49-54.
2. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol 2001;2:21-32.
3. Fu J, Bian M, Jiang Q, Zhang C. Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 2007;5:1-10.
4. Tanaka M, Ueda A, Kanamori H, Ideguchi H, Yang J, Kitajima S, et al. Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J Biol Chem 2002;277: 10719-26.
5. Honda K, Mihara H, Kato Y, Yamaguchi A, Tanaka H, Yasuda H, et al. Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway. Oncogene 2000;19: 2812-9.
6. Littlepage LE, Wu H, Andresson T, Deanehan JK, Amundadottir LT, Ruderman JV. Identification of phosphorylated residues that affect the activity of the mitotic kinase Aurora-A. Proc Natl Acad Sci U S A 2002;99:15440-5.
7. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998;20:189-93.
8. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998;17:3052-65.
9. Gritsko TM, Coppola D, Paciga JE, Yang L, Sun M, Shelley SA, et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 2003;9: 1420-6.
10. Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004;10: 2065-71.
11. Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, et al. Tumour-Amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer 2001;84:824-31.
12. Goepfert TM, Adigun YE, Zhong L, Gay J, Medina D, Brinkley WR. Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis. Cancer Res 2002;62: 4115-22.
13. Glover DM, Leibowitz MH, McLean DA, Parry H. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell 1995;81:95-105.
14. Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000;6:1833-9.
15. Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res 1994;54:4257-60.
16. Tanner MM, Tirkkonen M, Kallioniemi A, Holli K, Collins C, Kowbel D, et al. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. Clin Cancer Res 1995;1:1455-61.
17. Lai CH, Tseng JT, Lee YC, Chen YJ, Lee JC, Lin BW, et al. Translational up-regulation of Aurora-A in EGFR-overexpressed cancer. J Cell Mol Med 2010;14:1520-31.
18. Palmiter RD. Regulation of protein synthesis in chick oviduct. I. Independent regulation of ovalbumin, conalbumin, ovomucoid, and lysozyme induction. J Biol Chem 1972;247:6450-61.
19. Kozak M. An analysis of 50-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987;15:8125-48.
20. Gingras AC, Raught B, Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999;68:913-63.
21. Merrick WC. Cap-dependent and cap-independent translation in eukaryotic systems. Gene 2004;332:1-11.
22. Jackson RJ, Hunt SL, Reynolds JE, Kaminski A. Cap-dependent and cap-independent translation: operational distinctions and mechanistic interpretations. Curr Top Microbiol Immunol 1995;203:1-29.
23. Jackson RJ, Kaminski A. Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. RNA 1995;1:985-1000.
24. Stein I, Itin A, Einat P, Skaliter R, Grossman Z, Keshet E. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol 1998;18: 3112-9.
25. Holcik M, Lefebvre C, Yeh C, Chow T, Korneluk RG. A new internalribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat Cell Biol 1999;1:190-2.
26. Pyronnet S, Pradayrol L, Sonenberg N. A cell cycle-dependent internal ribosome entry site. Mol Cell 2000;5:607-16.
27. Stoneley M, Willis AE. Cellular internal ribosome entry segments: structures, trans-Acting factors and regulation of gene expression. Oncogene 2004;23:3200-7.
28. Cornelis S, Bruynooghe Y, Denecker G, Van Huffel S, Tinton S, Beyaert R. Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol Cell 2000;5:597-605.
29. Stoneley M, Paulin FE, Le Quesne JP, Chappell SA, Willis AE. C-Myc 50 untranslated region contains an internal ribosome entry segment. Oncogene 1998;16:423-8.
30. Creancier L, Morello D, Mercier P, Prats AC. Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation. J Cell Biol 2000;150:275-81.
31. Martineau Y, Le Bec C, Monbrun L, Allo V, Chiu IM, Danos O, et al. Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Mol Cell Biol 2004;24:7622-35.
32. van der Velden AW, Thomas AA. The role of the 50 untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 1999;31:87-106.
33. Dobson T, Minic A, Nielsen K, Amiott E, Krushel L. Internal initiation of translation of the TrkBmRNAismediated by multiple regions within the 50 leader. Nucleic Acids Res 2005;33:2929-41.
34. Holcik M, Korneluk RG. Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation. Mol Cell Biol 2000;20:4648-57.
35. Mitchell SA, Spriggs KA, Coldwell MJ, Jackson RJ, Willis AE. The Apaf-1 internal ribosome entry segment attains the correct structural conformation for function via interactions with PTB and unr. Mol Cell 2003;11:757-71.
36. Kollareddy M, Dzubak P, Zheleva D, Hajduch M. Aurora kinases: structure, functions and their association with cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008;152:27-33.
37. Wan XB, Long ZJ, Yan M, Xu J, Xia LP, Liu L, et al. Inhibition of Aurora-A suppresses epithelial-mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells. Carcinogenesis 2008;29:1930-7.
38. Schedin PJ, Eckel-Mahan KL, McDaniel SM, Prescott JD, Brodsky KS, Tentler JJ, Gutierrez-Hartmann A. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells. Oncogene 2004;23:1766-79.
39. Ford HL. Homeobox genes: A link between development, cell cycle, and cancer? Cell Biol Int 1998;22:397-400.
40. Sukhanov S, Higashi Y, Shai SY, Itabe H, Ono K, Parthasarathy S, et al. Novel effect of oxidized low-density lipoprotein: cellular ATP depletion via downregulation of glyceraldehyde-3-phosphate dehydrogenase. Circ Res 2006;99:191-200
41. Thomas JD, Johannes GJ. Identification of mRNAs that continue to associate with polysomes during hypoxia. RNA 2007;13:1116-31.
42. Kozak M. Evaluation of the "scanning model" for initiation of protein synthesis in eucaryotes. Cell 1980;22:7-8.
43. Lockard RE, Lane C. Requirement for 7-methylguanosine in translation of globin mRNA in vivo. Nucleic Acids Res 1978;5:3237-47.
44. De Benedetti A, Joshi-Barve S, Rinker-Schaeffer C, Rhoads RE. Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F. Mol Cell Biol 1991;11:5435-45.
45. Duncan R, Milburn SC, Hershey JW. Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. J Biol Chem 1987;262:380-8.
46. Hiremath LS, Webb NR, Rhoads RE. Immunological detection of the messenger RNA cap-binding protein. J Biol Chem 1985;260:7843-9.
47. Avdulov S, Li S, Michalek V, Burrichter D, Peterson M, Perlman DM, et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 2004;5:553-63.
48. De Benedetti A, Graff JR. eIF-4E expression and its role in malignancies and metastases. Oncogene 2004;23:3189-99.
49. Lazaris-Karatzas A, Smith MR, Frederickson RM, Jaramillo ML, Liu YL, Kung HF, et al. Ras mediates translation initiation factor 4E-induced malignant transformation. Genes Dev 1992;6:1631-42.
50. Ramirez-Valle F, Braunstein S, Zavadil J, Formenti SC, Schneider RJ. eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. J Cell Biol 2008;181:293-307.
51. Haghighat A, Sonenberg N. eIF4G dramatically enhances the binding of eIF4E to the mRNA 50-cap structure. J Biol Chem 1997;272: 21677-80.
52. Dobson T, Kube E, Timmerman S, Krushel LA. Identifying intrinsic and extrinsic determinants that regulate internal initiation of translation mediated by the FMR1 50 leader. BMC Mol Biol 2008;9:89.
53. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 1999;13:1422-37.
54. Jan E, Sarnow P. Factorless ribosome assembly on the internal ribosome entry site of cricket paralysis virus. J Mol Biol 2002;324:889-902.
55. Jang SK, Davies MV, Kaufman RJ, Wimmer E. Initiation of protein synthesis by internal entry of ribosomes into the 50 nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol 1989; 63:1651-60.
56. Van Eden ME, Byrd MP, Sherrill KW, Lloyd RE. Demonstrating internal ribosome entry sites in eukaryotic mRNAs using stringent RNA test procedures. RNA 2004;10:720-30.
57. Thompson SR. So you want to know if your message has an IRES? Wiley Interdiscip Rev: RNA 2012;3:697-705.
58. Lewis SM, Holcik M. For IRES trans-Acting factors, it is all about location. Oncogene 2008;27:1033-5.
59. Tinton SA, Schepens B, Bruynooghe Y, Beyaert R, Cornelis S. Regulation of the cell-cycle-dependent internal ribosome entry site of the PITSLRE protein kinase: roles of Unr (upstream of N-ras) protein and phosphorylated translation initiation factor eIF-2alpha. Biochem J 2005;385:155-63.
60. Bergamini G, Preiss T, Hentze MW. Picornavirus IRESes and the poly (A) tail jointly promote cap-independent translation in a mammalian cell-free system. RNA 2000;6:1781-90.
61. Dehlin E, Wormington M, Korner CG, Wahle E. Cap-dependent deadenylation of mRNA. EMBO J 2000;19:1079-86.
62. Chiang PW, Carpenter LE, Hagerman PJ. The 50-untranslated region of the FMR1 message facilitates translation by internal ribosome entry. J Biol Chem 2001;276:37916-21.
63. Band V, editor. Tumor progression in breast cancer. Totowa, NJ: Humana Press; 1991.
64. Band V, Sager R. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports longterm growth of both cell types. Proc Natl Acad Sci U S A 1989;86: 1249-53.
65. Band V, Zajchowski D, Swisshelm K, Trask D, Kulesa V, Cohen C, et al. Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res 1990;50:7351-7.
66. Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F, Ohmura N, et al. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005;65:2899-905.
67. Neben K, Korshunov A, Benner A, Wrobel G, Hahn M, Kokocinski F, et al. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res 2004;64:3103-11.
68. Sen S, Zhou H, White RA. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 1997;14:2195-200.
69. Tseng YS, Lee JC, Huang CY, Liu HS. Aurora-A overexpression enhances cell-Aggregation of Ha-ras transformants through the MEK/ERK signaling pathway. BMC Cancer 2009;9:435.
70. Kozak M. A second look at cellular mRNA sequences said to function as internal ribosome entry sites. Nucleic Acids Res 2005;33:6593-602.
71. Holcik M. Targeting translation for treatment of cancer-A novel role for IRES? Curr Cancer Drug Targets 2004;4:299-311.
72. Coldwell MJ, Mitchell SA, Stoneley M, MacFarlane M, Willis AE. Initiation of Apaf-1 translation by internal ribosome entry. Oncogene 2000;19:899-905.
73. Sehgal A, Briggs J, Rinehart-Kim J, Basso J, Bos TJ. The chicken c-Jun 50 untranslated region directs translation by internal initiation. Oncogene 2000;19:2836-45.
74. Sherrill KW, Byrd MP, Van Eden ME, Lloyd RE. BCL-2 translation is mediated via internal ribosome entry during cell stress. J Biol Chem 2004;279:29066-74.
75. Yang DQ, Halaby MJ, Zhang Y. The identification of an internal ribosomal entry site in the 50-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene 2006;25:4613-9.
76. Bellodi C, Kopmar N, Ruggero D. Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J 2010;29:1865-76.
77. Montanaro L, Calienni M, Bertoni S, Rocchi L, Sansone P, Storci G, et al. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res 2010;70:4767-77.
78. Yoon A, Peng G, Brandenburger Y, Zollo O, Xu W, Rego E, et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 2006;312:902-6.
79. Braunstein S, Karpisheva K, Pola C, Goldberg J, Hochman T, Yee H, et al. A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell 2007;28:501-12.
80. Filbin ME, Kieft JS. Toward a structural understanding of IRES RNA function. Curr Opin Struct Biol 2009;19:267-76.
81. Belsham GJ, Sonenberg N. Picornavirus RNA translation: roles for cellular proteins. Trends Microbiol 2000;8:330-5.
82. Pilipenko EV, Blinov VM, Romanova LI, Sinyakov AN, Maslova SV, Agol VI. Conserved structural domains in the 50-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology 1989;168:201-9.
83. Vagner S, Galy B, Pyronnet S. Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites. EMBO Rep 2001;2: 893-8.
84. Beaudoin ME, Poirel VJ, Krushel LA. Regulating amyloid precursor protein synthesis through an internal ribosomal entry site. Nucleic Acids Res 2008;36:6835-47.
85. Chappell SA, Edelman GM, Mauro VP. A 9-nt segment of a cellular mRNA can function as an internal ribosome entry site (IRES) and when present in linked multiple copies greatly enhances IRES activity. Proc Natl Acad Sci U S A 2000;97:1536-41.
86. Jang GM, Leong LE, Hoang LT, Wang PH, Gutman GA, Semler BL. Structurally distinct elements mediate internal ribosome entry within the 50-noncoding region of a voltage-gated potassium channel mRNA. J Biol Chem 2004;279:47419-30.
87. Ali N, Siddiqui A. The La antigen binds 50 noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc Natl Acad Sci U S A 1997;94:2249-54.
88. Borovjagin A, Pestova T, Shatsky I. Pyrimidine tract binding protein strongly stimulates in vitro encephalomyocarditis virusRNAtranslation at the level of preinitiation complex formation. FEBS Lett 1994;351: 299-302.
89. Pfingsten JS, Costantino DA, Kieft JS. Structural basis for ribosome recruitment and manipulation by a viral IRES RNA. Science 2006;314: 1450-4.
90. Hellen CU, SarnowP. Internal ribosome entry sites in eukaryoticmRNA molecules. Genes Dev 2001;15:1593-612.
91. Gu L, Zhu N, Zhang H, Durden DL, Feng Y, Zhou M. Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell 2009;15:363-75.
92. Halaby MJ, Hibma JC, He J, Yang DQ. ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells. Cell Signal 2008;20: 1555-63.
93. Ohno S, Shibayama M, Sato M, Tokunaga A, Yoshida N. Polypyrimidine tract-binding protein regulates the cell cycle through IRES-dependent translation of CDK11(p58) in mouse embryonic stem cells. Cell Cycle 2011;10:3706-13.
94. Lee EC, Frolov A, Li R, Ayala G, Greenberg NM. Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res 2006; 66:4996-5002.
95. Kitzen JJ, de Jonge MJ, Verweij J. Aurora kinase inhibitors. Crit Rev Oncol Hematol 2010;73:99-110.
96. Mountzios G, Terpos E, Dimopoulos MA. Aurora kinases as targets for cancer therapy. Cancer Treat Rev 2008;34:175-82.
97. Dutertre S, Descamps S, Prigent C. On the role of aurora-A in centrosome function. Oncogene 2002;21:6175-83.